22 research outputs found
Perthes disease : A new finding in Floating-Harbor syndrome
Floating-Harbor Syndrome (FHS; OMIM #136140) is an ultra-rare autosomal dominant genetic condition characterized by expressive language delay, short stature with delayed bone mineralization, a triangular face with a prominent nose, and deep-set eyes, and hand anomalies. First reported in 1973, FHS is associated with mutations in the SRCAP gene, which encodes SNF2-related CREBBP activator protein. Mutations in the CREBBP gene cause Rubinstein-Taybi Syndrome (RSTS; OMIM #180849, #613684), another rare disease characterized by broad thumbs and halluces, facial dysmorphisms, short stature, and intellectual disability, which has a phenotypic overlap with FHS. We describe a case of FHS associated with a novel SRCAP mutation and characterized by Perthes disease, a skeletal anomaly described in approximately 3% of patients with RSTS. Thus Perthes disease can be added to the list of clinical features that overlap between FHS and RSTS
Data Analysis and Modeling to Optimize Thermal Treatment Cost and Performance
The objective of in situ thermal treatment is typically to reduce the contaminant mass or average soil concentration below a specified value. Evaluation of whether the objective has been met is usually made by averaging soil concentrations from a limited number of soil samples.Results from several field sites indicate large performance uncertainty using this approach, even when the number of samples is large. We propose a method to estimate average soil concentration by fi tting a log normal probability model to thermal mass recovery data. A statistical approach is presented for making termination decisions from mass recovery data, soil sample data, or both for an entire treatment volume or for subregions that explicitly considers estimation uncertainty which is coupled to a stochastic optimization algorithm to identify monitoring strategies to meet objectives with minimum expected cost. Early termination of heating in regions that reach cleanup targets sooner enables operating costs to be reduced while ensuring a high likelihood of meeting remediation objectives. Results for an example problem demonstrate that significant performance improvement and cost reductions can be achieved using this approach
Valutazione dei danni di salute in un campione di donne residenti nei pressi dell’aeroporto Malpensa 2000
Platinum–bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis
Studio epidemiologico Salus domestica : valutazione dei danni di salute in un campione di donne residenti nei pressi dell'aeroporto Malpensa 2000
Rapid customization system for 3D-printed splint using programmable modeling technique – a practical approach
Virtual reality as a countermeasure for astronaut motion sickness during simulated post-flight water landings
Abstract
Entry motion sickness (EMS) affects crewmembers upon return to Earth following extended adaptation to microgravity. Anticholinergic pharmaceuticals (e.g., Meclizine) are often taken prior to landing; however, they have operationally adverse side effects (e.g., drowsiness). There is a need to develop non-pharmaceutical countermeasures to EMS. We assessed the efficacy of a technological countermeasure providing external visual cues following splashdown, where otherwise only nauseogenic internal cabin visual references are available. Our countermeasure provided motion-congruent visual cues of an Earth-fixed scene in virtual reality, which was compared to a control condition with a head-fixed fixation point in virtual reality in a between-subject design with 15 subjects in each group. We tested the countermeasure’s effectiveness at mitigating motion sickness symptoms at the end of a ground-based reentry analog: approximately 1 h of 2Gx centrifugation followed by up to 1 h of wave-like motion. Secondarily, we explored differences in vestibular-mediated balance performance between the two conditions. While Motion Sickness Questionnaire outcomes did not differ detectably between groups, we found significantly better survival rates (with dropout dictated by reporting moderate nausea consecutively over 2 min) in the visual countermeasure group than the control group (79% survival vs. 33%, t(14) = 2.50, p = 0.027). Following the reentry analogs, subjects demonstrated significantly higher sway prior to recovery (p = 0.0004), which did not differ between control and countermeasure groups. These results imply that providing motion-congruent visual cues may be an effective mean for curbing the development of moderate nausea and increasing comfort following future space missions